Top Stories
-
Columbia researchers conducted a systematic review, determining which suicide prevention strategies work, and are scalable to national levels.
Topic
-
Source:
Everyday HealthIt’s not clear yet, based on current data, whether fish oil can work as an antidepressant, says Dr. Philip Muskin.
Topic
-
Source:
gizmodo.com"Many patients report rapid improvement in mood, anxiety and hedonic function, which is what initially attracted the psychiatric profession to the use of ketamine," said Dr. Joshua Berman.
Topic
-
Source:
CNN"There is generally more sadness in the winter time and January is not uncommon at all for overall more sadness among folks," said Dr. Ravi Shah.
Topic
Latest News
-
Source:
InsiderAugust 26, 2019While there is still plenty of research to be done, Dr. Philip Muskin emphasized that there is enough certainty to know that psychiatric drugs do work – often to great effect.
Topic
-
Source:
SCIENCE MAGAZINEAugust 23, 2019Scientists have already found several brain features that align with suicide risk. The best studied comes from neuroscientist Dr. John Mann.
Topic
-
Source:
MedscapeJune 20, 2019Dr. Elizabeth Fitelson discusses what we can expect from brexanolone, a drug developed specifically to counteract unique physiologic changes that can induce postpartum depression in vulnerable women.
Topic
-
Source:
MedscapeJune 20, 2019Dr. Elizabeth Fitelson discusses perinatal depression.
Topic
- May 15, 2019
Optimizing Outcomes of Treatment-Resistant Depression in Older Adults (OPTIMUM) is the largest study ever done on late-life depression. OPTIMUM’s New York site is located at NYSPI/Columbia.
Topic
-
Source:
US News & World ReportApril 4, 2019Prescription medication may be enormously helpful, but "just taking a pill is usually not enough" to effectively cope with depression, says Dr. Diana Samuel.
Topic
-
Source:
Wall Street JournalApril 1, 2019“Part of the problem that we’re faced within the field is that we really need to become better at identifying the factors that lead to the escalation of suicide risk,” says Dr. Randy Auerbach,
Topic
-
Source:
New York TimesMarch 24, 2019Dr. Kelly Posner Gerstenhaber has developed a protocol of questions that anyone — not just medical professionals — can ask to identify people who may be at risk of suicide.
Topic
-
Source:
MD MagazineMarch 8, 2019Dr. Jeffrey Lieberman’s concerns about whether dosing strategies for ketamine have been properly set by clinical trials are mentioned in this Q&A.
Topic
-
Source:
HealioMarch 6, 2019“Approval of esketamine is important for patients because other options like transcranial magnetic stimulation work more poorly in medication-resistant depression,” writes Dr. J. John Mann. .
Topic
